Ethanol Sclerotherapy
Cross-source consensus on Ethanol Sclerotherapy from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Preparation
Evidence quality
Highlighted claims
- The ATOPE observational arm treats endometriomas larger than 6 cm with laparoscopic sclerotherapy. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- The trial uses a standardized 10-minute, 10-step ethanol sclerotherapy protocol. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Prospective data confirming the safety and fertility effectiveness of sclerotherapy are absent. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Retrospective observational studies of sclerotherapy in large endometriomas reported a moderate AMH decline and a 57% pregnancy rate at 24 months. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Ethanol sclerotherapy has emerged as a promising minimally invasive alternative for endometriomas larger than 6 cm. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts